HKHong Nyun Kim

Hong Nyun Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hong Nyun Kim has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long‐Term Clinical Outcomes of Acute Myocardial Infarction Based on Institutional Experience With IVUS

    by Youngjoon Kwon, Namkyun Kim, Do‐Hoon Kim, Byungwon Kim, Jong Sung Park, Yoon Jung Park, Bo Eun Park, Hong Nyun Kim, Jang Hoon Lee, Dong Heon Yang, et al.

    Background: Intravascular ultrasound (IVUS)‐guided percutaneous coronary intervention improves patient outcomes, yet the impact of a center's IVUS experience on long‐term outcomes remains unclear. We evaluated whether the prognostic association of IVUS‐guided percutaneous coronary intervention in patients with acute myocardial infarction differs based on a center's level of IVUS use. Methods: We retrospectively analyzed 9752 patients with acute myocardial infarction treated with second‐generation drug‐eluting stents from the KAMIR‐NIH (Korean Acute Myocardial Infarction Registry–National Institutes of Health). The primary outcome was 3‐year major adverse cardiovascular events, defined as a composite of all‐cause death, myocardial infarction, and coronary revascularization. The secondary outcome was target‐lesion failure, defined as a composite of cardiac death, target‐vessel myocardial infarction, and ischemia‐driven target lesion revascularization. Centers were classified into higher‐ or lower‐IVUS‐use groups on the basis of median institutional usage (10.3%). Results: In higher‐use centers, IVUS‐guided percutaneous coronary intervention was associated with lower rates of major adverse cardiovascular events (15.3% versus 18.5%, P =0.016) and target‐lesion failure (6.3% versus 8.3%, P =0.039) in propensity score–matched populations. Multivariate Cox analysis confirmed lower risks of major adverse cardiovascular events (hazard ratio [HR], 0.80 [95% CI, 0.69–0.93]; P =0.003) and target‐lesion failure (HR, 0.75 [95% CI, 0.59–0.93]; P =0.01). Conversely, in lower‐use centers, IVUS guidance was not associated with significant differences in major adverse cardiovascular events (15.7% versus 18.6%, P =0.422) or target‐lesion failure (8.9% versus 10.4%, P =0.644). Conclusions: The association of IVUS‐guided percutaneous coronary intervention with lower adverse event rates was more apparent and statistically demonstrable in centers with higher IVUS use. These findings suggest that institutional experience may amplify the observable impact of IVUS guidance, underscoring the potential value of standardized IVUS implementation in acute myocardial infarction management.

  • Open Access

    Acute decompensated heart failure after transcatheter aortic valve implantation: A case report

    by Hong Nyun Kim, Dong Heon Yang, Bo Eun Park

    Key Clinical Message: Transcatheter aortic valve implantation (TVAI) is a widely used treatment modality for severe aortic stenosis. The complication rates of the procedure have gradually decreased over time, owing to the improvements in procedural skills and development of TVAI devices. However, several rare but serious complications can still occur after TAVI. We recently encountered acute decompensated heart failure as a rare and fatal complication of TAVI and would like to share our experience.


  • Open Access

    Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA2DS2‐VASc score of 0

    by Hyohun Choi, Myung Hwan Bae, Yoon Jung Park, Hyuk Kyoon Park, Eunkyu Lee, Myeong Seop Kim, Jong Sung Park, Hyeon Jeong Kim, Bo Eun Park, Hong Nyun Kim, et al.

    Background: Anticoagulant therapy has been important for stroke prevention in patients with atrial fibrillation (AF). However, it was not recommended due to its relatively higher risk of bleeding than its lower risk of stroke in patients with a CHA2DS2‐VASc score of 0.Hypothesis: This study aimed to evaluate the predictors of stroke in AF patients with very low risk of stroke.Methods: Between 1990 and 2020, 542 patients with non‐valvular AF (NVAF) with a CHA2DS2‐VASc score of 0 followed up for at least 6 months were enrolled. Patients with only being woman as a risk factor were included as a CHA2DS2‐VASc score of 0 in this study. The primary outcome was stroke or systemic embolism.Results: The primary outcome rate was 0.78%/year. In Cox hazard model, age of ≥50 years at diagnosis (hazard ratio [HR] 6.710, 95% confidence interval [CI] 1.811–24.860, p = .004), LVEDD of ≥46 mm (HR 4.513, 95% CI 1.038–19.626, p = .045), and non‐paroxysmal AF (HR 5.575, 95% CI 1.621–19.175, p = .006) were identified as independent predictors of stroke or systemic embolism. Patients with all three independent predictors had a higher risk of stroke or systemic embolism (4.21%/year), whereas those without did not have a stroke or systemic embolism.Conclusion: The annual stroke or systemic embolism rate in NVAF patients with CHA2DS2‐VASc score of 0 was 0.78%/year, and age at AF diagnosis, LVEDD, and non‐paroxysmal AF were independent predictors of stroke or systemic embolism in patients considered to have a very low risk of stroke.


  • Open Access

    Impact of Positron Emission Tomography Viability Imaging: Guided Revascularizations on Clinical Outcomes in Patients With Myocardial Scar on Single-Photon Emission Computed Tomography Scans

    by Jong Sung Park, Jang Hoon Lee, Chae Moon Hong, Bo Eun Park, Yoon Jung Park, Hong Nyun Kim, Namkyun Kim, Se Yong Jang, Myung Hwan Bae, Dong Heon Yang, et al.

    Park JS, et al. J Korean Med Sci. 2023 Nov;38:e399. https://doi.org/10.3346/jkms.2023.38.e399


  • Open Access

    Acute Decompensated Heart Failure after Transcatheter Aortic Valve Implantation: A Case Report

    by Hong Nyun Kim, Dong Heon Yang

    Transcatheter aortic valve implantation (TVAI) is a widely used treatment for aortic stenosis. The complication rates of TAVI have decreased over time, owing to the improvements in procedural skills.We encountered acute decompensated heart failure cause by stress induced cardiomyopathy or ventricular stunning as a rare and fatal complication of TAVI.

  • Open Access

    Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction

    by Hyohun Choi, Jang Hoon Lee, Hyuk Kyoon Park, Eunkyu Lee, Myeong Seop Kim, Hyeon Jeong Kim, Bo Eun Park, Hong Nyun Kim, Namkyun Kim, Se Yong Jang, et al.

    Choi H, et al. J Korean Med Sci. 2022 May;37(21):e167. https://doi.org/10.3346/jkms.2022.37.e167


  • Open Access

    Prognostic impact of chromogranin A in patients with acute heart failure

    by Hong Nyun Kim, Dong Heon Yang, Bo Eun Park, Yoon Jung Park, Hyeon Jeong Kim, Se Yong Jang, Myung Hwan Bae, Jang Hoon Lee, Hun Sik Park, Yongkeun Cho, et al.

    Background: Chromogranin A (CgA) levels have been reported to predict mortality in patients with heart failure. However, information on the prognostic value and clinical availability of CgA is limited. We compared the prognostic value of CgA to that of previously proven natriuretic peptide biomarkers in patients with acute heart failure.Methods: We retrospectively evaluated 272 patients (mean age, 68.5±15.6 years; 62.9% male) who underwent CgA test in the acute stage of heart failure hospitalization between June 2017 and June 2018. The median follow-up period was 348 days. Prognosis was assessed using the composite events of 1-year death and heart failure hospitalization.Results: In-hospital mortality rate during index admission was 7.0% (n=19). During the 1-year follow-up, a composite event rate was observed in 12.1% (n=33) of the patients. The areas under the receiver-operating characteristic curves for predicting 1-year adverse events were 0.737 and 0.697 for N-terminal pro-B-type natriuretic peptide (NT-proBNP) and CgA, respectively. During follow-up, patients with high CgA levels (>158 pmol/L) had worse outcomes than those with low CgA levels (≤158 pmol/L) (85.2% vs. 58.6%, p<0.001). When stratifying the patients into four subgroups based on CgA and NT-proBNP levels, patients with high NT-proBNP and high CgA had the worst outcome. CgA had an incremental prognostic value when added to the combination of NT-proBNP and clinically relevant risk factors.Conclusion: The prognostic power of CgA was comparable to that of NT-proBNP in patients with acute heart failure. The combination of CgA and NT-proBNP can improve prognosis prediction in these patients.


  • Open Access

    A case of paroxysmal complete atrioventricular block in a COVID‐19 patient

    by Hong Nyun Kim, Myung Hwan Bae, Bo Eun Park, Jaehee Lee

    Many types of cardiac arrhythmias can occur in people with COVID‐19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID‐19 and would like to share the course of treatment.


  • Open Access

    A Case of Paroxysmal Complete Atrioventricular Block in a COVID-19 Patient

    by Hong Nyun Kim, Myung Hwan Bae, Bo Eun Park, Jaehee Lee

    A patient with coronavirus disease 2019 showed complete atrioventricular block on electrocardiogram. The patient was undergoing mechanical ventilator treatment for severe hypoxia. Intrathoracic pressure was reduced by adjusting the tidal volume and the positive end-expiratory pressure of the mechanical ventilator. After that, complete atrioventricular block didn't occur during the hospitalization.

  • Open Access

    Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City

    by Bo Eun Park, Jang Hoon Lee, Hyuk Kyoon Park, Hong Nyun Kim, Se Yong Jang, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Bong Yul Lee, et al.

    Park BE, et al. J Korean Med Sci. 2020 Oct;36(2):e15. https://doi.org/10.3346/jkms.2021.36.e15